1. Upper GI SSG Meeting Statistics

2. Background The SSG agreed to start looking at some data/indicators
As a starting point, eight metrics were proposed
This information is intended as a starting point to help shape our ideas for review of data in the SSG

3. Questions to consider
Are these the right metrics? (We can change but not increase number) Could we discuss different ones each time?
How can we get data from the whole region for HPB indicators?
Is the data timely enough (most recent available NOGCA data is 15/16)
Is it useful to discuss these at SSGs? How could they be more useful?

4. OG - % patients diagnosed after emergency admission
Source: NOGCA audit, patients diagnosed 14/15 financial year
% adjusted rate
All within NOGCA’s acceptable range
Bath
3.1
NBT
6.9
Taunton
UH Bristol
5.3
Weston
13.9
Yeovil
5.1

5. OG - % patients who had a staging CT scan
Source: NOGCA audit, patients diagnosed 14/15 financial year
All below NOGCA’s acceptable threshold but likely missing data rather than not staged
Bath 78
NBT 89
Taunton 88
UH Bristol 81
Weston 90
Yeovil 56

6. OG - % patients discussed at Specialist MDT with curative treatment pan
Source: Bristol cancer register, patients diagnosed 15/16 financial year and eligible for NOGCA audit
41%
National % (note two year period) per NOGCA audit: 37.6%

7. OG - % patients who had ≥ 15 lymph nodes removed at resection
Source: NOGCA audit, patients diagnosed 14/15 financial year
UH Bristol – 90.8% (above national average)

8. HPB – % pancreatic cancer patients having resection
Source: UH Bristol/NBT shared Cancer Register, waiting times dataset
Patients first seen at UH Bristol or NBT in 2016/17 financial year: 22%

9. HPB - % patients with HCC who have a resection or RFA
Source: UH Bristol/NBT shared Cancer Register, waiting times dataset
Patients first seen at UH Bristol or NBT in 2016/17 financial year: 34%

10. HPB - Number of resections for liver metastases
Source: UH Bristol/NBT shared cancer register, resections undertaken in 2016/17 financial year
44 (plus 5 RFAs)

11. HPB - % patients with recorded staging
Source: UH Bristol/NBT shared cancer register, diagnosed 2016/17 financial year, treated or first seen at UH BristoL
8% (national target 70%)
Needs clinical support to state staging in MDT so it can be recorded.
National drive to improve staging

12. Next steps
What metrics would we like to review next meeting? (Maximum of 8)
How can we ensure complete data?
What format would we like the information in?